Where Torrid Holdings Stands With Analysts
Torrid Holdings (NYSE:CURV) has observed the following analyst ratings within the last quarter:
60 Biggest Movers From Yesterday
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.
Torrid Stock Plummets On Q4, FY21 Outlook Cut
Torrid Holdings Inc (NYSE:CURV) has cut its fourth-quarter sales outlook to $300 million – $305 million (previous view $325 million –…
45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
Mid-Morning Market Update: Markets Open Lower; AZZ Profit Tops Views
Following the market opening Monday, the Dow traded down 0.95% to 35,888.97 while the NASDAQ fell 1.59% to 14,699.18. The S&P also fell, dropping, 1.27% to 4,617.70.
Morgan Stanley Maintains Equal-Weight on Torrid Holdings, Lowers Price Target to $12
Morgan Stanley analyst Kimberly Greenberger maintains Torrid Holdings (NYSE:CURV) with a Equal-Weight and lowers the price target from $14 to $12.
Morgan Stanley Downgrades Torrid Holdings to Equal-Weight, Lowers Price Target to $14
Morgan Stanley analyst Kimberly Greenberger downgrades Torrid Holdings (NYSE:CURV) from Overweight to Equal-Weight and lowers the price target from $28 to $14.
